Research Article
Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study
Table 3
Correlations of serum IL-31 and IL-33 levels with clinical factors in patients with EC (pg/mL). Data is shown as mean ± standard deviation (SD).
| Characters | Number of patients (%) | Serum IL-31 | value | Serum IL-33 | value |
| Age (years) | | | | | | <60 | 108 (67.5%) | 170.87 ± 33.05 | 0.335 | 110.36 ± 7.69 | 0.062 | ≥60 | 52 (32.5%) | 181.37 ± 29.11 | | 105.73 ± 7.70 | | BMI | | | | | | 18.5 ≤ BMI ≤ 24.99 | 72 (45%) | 162.76 ± 37.98 | 0.859 | 108.11 ± 8.36 | 0.818 | 25 ≤ BMI ≤ 28 | 68 (42.5%) | 169.85 ± 38.89 | | 109.71 ± 6.77 | | BMI > 28 | 20 (12.5%) | 163 ± 50.57 | | 108.6 ± 6.6 | | Tumor stages | | | | | | S1 and S2 | 88 (55%) | 164.18 ± 22.09 | 0.024 | 106.66 ± 6.27 | 0.035 | S3 and S4 | 72 (45%) | 186.63 ± 37.80 | | 111.54 ± 7.88 | | Depth of invasion | | | | | | T1 and T2 | 108 (67.5%) | 169.04 ± 29.38 | 0.182 | 106.53 ± 6.27 | 0.008 | T3 and T4 | 52 (32.5%) | 183.01 ± 34.84 | | 112.72 ± 7.62 | | Lymph node metastasis | | | | | | Absent | 124 (77.5%) | 169.86 ± 27.08 | 0.104 | 107.50 ± 4.45 | 0.029 | Present | 36 (22.5%) | 189.52 ± 37.85 | | 113.52 ± 9.27 | | Distant metastasis | | | | | | M0 | 120 (75%) | 169.50 ± 29.51 | 0.100 | 107.24 ± 6.20 | 0.014 | M1 | 40 (25%) | 188.63 ± 35.80 | | 113.71 ± 8.76 | |
|
|
value means the results of IL-31 with the clinical factors. value means the results of IL-33 with the clinical factors.
|